SSN News 0.34 05/05/2014 05:32:57 Samson Oil & Gas Limited (

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Samson Oil & Gas Limited (SSN) 0.34 $SSN

Samson Oil & Gas Advisory
Business Wire - Wed Apr 30, 7:30PM CDT
Samson Oil & Gas Limited (ASX: SSN; NYSE MKT: SSN):

Samson Oil & Gas Lodges March 2014 Quarterly Report and Appendix 5B
Business Wire - Tue Apr 29, 6:45PM CDT
Samson Oil & Gas Limited (ASX: SSN, NYSE AMEX: SSN) advises that it has filed its Quarterly Report for the period ended March 31st, 2014 and Appendix 5B. The report is now available on the Company's website:

Samson Oil & Gas Operational Advisory
Business Wire - Mon Apr 28, 7:30PM CDT
Samson Oil & Gas Limited (ASX: SSN; NYSE MKT: SSN):

Samson Oil & Gas Announces Equity Placement
Business Wire - Wed Apr 16, 7:35PM CDT
Samson Oil & Gas Limited ("Samson" or the "Company" (ASX:SSN; NYSE MKT:SSN) announced today that it has placed 65,000,000 ordinary shares to investors in Australia and 11,255,541 American Depositary Shares (ADSs) (representing 225,110,820 ordinary shares) to investors based in the United States to raise gross proceeds of A$5,802,217 (US$5,439,578). The placement was completed at $0.02 per ordinary share (approximately US$0.375 per ADS), and includes options, or warrants, to purchase an additional 3 shares for each 10 shares subscribed for, at an exercise price of A$0.033 (approximately $0.61 per ADS). The options/warrants will expire on 30 April 2018.

Samson Oil & Gas IPAA New York Presentation
Business Wire - Sun Apr 06, 7:30PM CDT
IPAA NEW YORK CONFERENCE --Samson Oil & Gas Limited (ASX: SSN; NYSEMKT: SSN) advises that its CEO, Terry Barr will be presenting to delegates attending "The 2014 IPAA Conference" being held in New York April 7-9.

Energy Sector Stocks Coverage -- Research on Pioneer Natural Resources, EQT Corp., Rex Energy, and Samson Oil & Gas
PR Newswire - Tue Apr 01, 8:12AM CDT
On Monday, March 31, 2014, the NASDAQ Composite ended at 4,198.99, up 1.04%, the Dow Jones Industrial Average advanced 0.82% to 16,457.66, and the S&P 500 closed at 1,872.34, up 0.79%. The gains were broad based as nine out of 10 sectors ended the session in positive. The S&P 500 Energy Sector Index finished the day at 652.90, down 0.01%, while the same has charted up 2.28% in the last one month. Investor-Edge has initiated coverage on the following equities: Pioneer Natural Resources Co. (NYSE: PXD), EQT Corp. (NYSE: EQT), Rex Energy Corp. (NASDAQ: REXX) and Samson Oil & Gas Ltd (NYSE MKT: SSN). Free technical research on PXD, EQT, REXX and SSN can be downloaded upon signing up at:

Research and Markets: Global Residential Robotic Vacuum Cleaner Market 2014-2018 with iRobot, LG, Neato & Samsung Dominating the Industry
Business Wire - Thu Feb 20, 9:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/kq7766/global) has announced the addition of the "Global Residential Robotic Vacuum Cleaner Market 2014-2018 with iRobot, LG, Neato & Samsung Dominating the Industry" report to their offering.

BioTime CEO Dr. Michael West to Present at 9th Annual Stem Cell Summit
Business Wire - Tue Feb 18, 7:45AM CST
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the 9th Annual Stem Cell Summit in New York. Dr. West will speak in the session "Disrupting the Pharma Model with Allogeneic Stem Cell Therapies" on February 18, 2014, starting at 9:05 a.m. EST.

Samson Oil & Gas Enercom San Francisco Presentation
Business Wire - Sun Feb 16, 7:00PM CST
Samson Oil & Gas Limited (ASX: SSN; NYSE AMEX: SSN):
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BASIS Bellevue Expands with New K-4 Campus

Updated Category News Views 89

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

Continue Reading
Smirnoff Launches Marvel Event with $12.99 Offer

Updated Category News Views 68

Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...

Continue Reading
Ameritas Hires Actuarial Veteran as VP in Strategic Move

Updated Category News Views 115

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

Continue Reading
Amgen Q3 2026 Results: What Investors Should Know

Updated Category News Views 93

Amgen Prepares to Reveal Third Quarter 2026 Financials If there's one thing I've learned about investing, it's that the devil's in the details, and Amgen's (NASDAQ:AMGN) upcoming webcast for its third quarter 2026 financial results is exactly the kind of detail that sets market-watchers' hearts racing. Scheduled for November 3, just after the U.S. markets close, this is...

Continue Reading
Royce Global Trust: Insights on RGT's Performance

Updated Category News Views 80

Analyzing Royce Global Trust's Approach When you dig into the Royce Global Trust portfolio, what emerges is a tapestry woven through decades of grit and determination in the investing world. This closed-end fund, trading under the symbol NYSE: RGT, is no stranger to the ebbs and flows of global markets. With every tick of the clock, speculation dances around this fund's...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Bloomberg Law Awards Series Celebrates Legal Excellence

Updated Category News Views 54

New Awards Shine Light on Corporate Legal Teams Here's one for the books: Bloomberg Law is rolling out a shiny new awards program called Inside In-House: Legal Departments of the Year. Now, this isn't some vanity affair because it's aimed at celebrating the folks in legal teams who make companies tick behind the scenes. Openings for nominations run through November 20,...

Continue Reading
Oracle's Bold Vision: Targeting $225B Revenue by 2030

Updated Category News Views 132

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Continue Reading
BD's New Liverty™ TIPS Stent: A Game Changer?

Updated Category News Views 75

Could This Be the Breakthrough for Portal Hypertension? Now, here's something that might just turn a few heads in the medical world. BD has launched their Liverty™ TIPS Stent Graft in the U.S., a move set to shake up the landscape for treating portal hypertension. This isn't just another shiny new gadget—it's a promise of more personalized patient care in a field...

Continue Reading
Ascletis' ASC30 Achieves Significant HbA1c Reductions

Updated Category News Views 73

When you dive into the world of biopharma, you never quite know what's going to grab your attention next. Today, it's Ascletis Pharma's (HKEX: 1672) GLP-1 receptor agonist, ASC30, that's piqued my interest. It just wrapped up a U.S. Phase II study with a bang, showing off with some impressive results for type 2 diabetes treatment. This ain't no half-hearted...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading